# Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Studies of the Effects of Influenza Antiviral Agents, Funding Opportunity Announcement (FOA) IP07-003, and Epidemiology of Influenza in Tropical Developing Countries, FOA IP07-004
In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces a meeting of the aforementioned Special Emphasis Panel.
*Time and Date:* 12 p.m.-4 p.m., July 10, 2007 (Closed).
*Place:* Teleconference.
*Status:* The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
*Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of research grant applications in response to FOA IP07-003, “Studies of the Effects of Influenza Antiviral Agents,” and FOA IP-07-004 “Epidemiology of Influenza in Tropical, Developing Countries.”
*CONTACT PERSON FOR MORE INFORMATION:* Trudy Messmer, PhD, Scientific Review Administrator, 1600 Clifton Road, Mailstop C-19, Atlanta, GA 30333, telephone (404) 639-3770.
The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: June 1, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.